Lobbying Filing Details

Total Spending

$220,000

Activities

1

Lobbyists

2

Gov't Entities

2

Filing Information
Filing UUID:
cc556cbe-eb32-4100-9ee2-f112bd0a84fb
Type:
Q3 - 3rd Quarter - Report
Period:
2024 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 21, 2024 at 8:19 PM
Income:
$0
Expenses:
$220,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Amanda Pezalla
Registrant
DAIICHI SANKYO, INC.
Basking Ridge, New Jersey
Client
DAIICHI SANKYO INC
District of Columbia, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Discussions regarding H.R.5539, the ORPHAN Cures Act Discussions related to H.R.4534 - the Women and Lung Cancer Research and Preventive Services Act Discussions related to H.R.5391 - the Protecting Patient Access to Cancer and Complex Therapies Act 340B reform generally as well as H.R.8574 - the 340B ACCESS Act

Foreign Entity Issues: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.

Lobbyists (2)
  • AMANDA PEZALLA
  • AARON BILL
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 12, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.